Pathogen Data Sharing: Balancing Global Health Security and Equity

The Battle Over Global Outbreak Rules

Equitable access to pathogen genomic data remains a critical public health challenge as the World Health Organization works to finalize binding rules for global outbreak responses.

Inequities in International Data Flows

The current negotiations aim to address longstanding disparities in how outbreak data is utilized internationally. Many disease outbreaks originate in lower-income countries, where local health workers and scientists collect samples and generate genetic sequences.

However, those sequences are frequently used by well-resourced institutions in wealthy nations to develop proprietary diagnostic tests, therapeutics, and patents, leaving the source countries with little tangible return on their contributions.

Historical Precedents and Security Risks

This structural imbalance creates severe security risks alongside equity concerns. When nations see little benefit from sharing vital genomic information during an emerging health crisis, they may withhold data to protect domestic interests.

A prominent historical precedent occurred in 2006, when Indonesia temporarily stopped sharing influenza virus samples with the World Health Organization over concerns that developing nations would be priced out of resulting vaccines.

Shortfalls in the PABS Framework

While the framework provides tools to manage immediate emergencies, it largely overlooks the foundational steps required to establish enduring, equitable practices between high- and low-income nations.